基于液固压缩技术的伊曲康唑速释制剂分析-analysis of itraconazole rapid release preparation based on liquid-solid compression technology.docxVIP

基于液固压缩技术的伊曲康唑速释制剂分析-analysis of itraconazole rapid release preparation based on liquid-solid compression technology.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
基于液固压缩技术的伊曲康唑速释制剂分析-analysis of itraconazole rapid release preparation based on liquid-solid compression technology

AbstractThus far, about 40% of promising pharmacological active substances have bioavailability problem due to their poor solubility, which restricts the development of new drugs to a certain extent. Many common technologies are available today for dissolution rate enhancement, but these involve high production cost, sophisticated machinery, complicated technologies, intellectual property issues, and advanced preparation methods. However, the emergence of liquisolid technology overcomes these barriers.It has been proved that the liquisolid technology can significantly increase the solubility of water-insoluble drugs, improving the bioavailability, especially for the low dose water-insoluble drugs.However, In order to have acceptable flowability and compactability for liquisolid powder formulation, high levels of carrier and coating materials should be added and that in turn will increase the weight of each tablet which is very difficult to swallow, formulation of the high dose insoluble-drugs as liquisolid tablets is one of the limitations of the liquisolid technique. Also,few research of the liquisolid technology has been reported, especially for the study of its solubilization mechanism, and the conclusion is not consistent. Therefore, further research and exploration of the solubilization mechanism in liquisolid technology is necessary.As a broad-spectrum antimicrobial agent, itraconazole has a superiority in low minimum bacteriostatic concentration, high security and good efficacy, but the water-insolubility reduce its clinical pharmacological effects. More over,during the preparation process of itraconazole pellet,huge amounts of dichloromethane is needed to dissolve the drugs and HPMC, this process need high -level equipment and cause pollution.There are also some reports about self-emulsifying formulation and solid dispersion technique,but both of them have a complex preparation process and low yield.In order to solve the problem above, this research use itra

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档